SA vaccine maker Biovac to get R2.3bn to fund expansion
A consortium of development finance institutions aims to raise the money to enable the facility to produce up to 1-billion doses a year
01 March 2022 - 11:00
State-backed vaccine manufacturer Biovac has clinched a deal with a consortium of development finance institutions to raise $150m (R2.3bn) to fund the expansion of its Cape Town-based facility, to produce up to 1-billion doses a year.
It bolsters SA’s plans to increase its domestic vaccine production capacity, and reduce the risk of standing at the back of the queue again in future health emergencies. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.